GFAP concentrations in participants with a C9orf72, GRN or MAPT mutation did not differ from FTD participants with no mutation, nor did GFAP differ among the three mutation groups when performing pair-wise comparisons (Fig. 6a, Tables S27 and S28). The gene discussed is MAPT; the disease is frontotemporal dementia.